Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryopreserved vs. Liquid-Stored Platelets for Surgical Bleeding
NCT03991481Phase 3Active, not recruiting
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Start
- Aug 2021
- Primary completion
- Jul 2024
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cryopreserved platelets in hemorrhage, sponsored by Australian and New Zealand Intensive Care Research Centre. Primary endpoint: Volume of post-surgical bleeding in the first 24 hours. Started Aug 2021; status: active, not recruiting.
02
Drugs
cryopreserved platelets
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03991481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03991481.